Bio-Rad Laboratories Reports Q4 Earnings Surge, Up 23% To $159M

Bio-Rad Laboratories (BIO) reported fourth-quarter net income of $159 million, a 23% increase from the prior-year period, driven by higher demand for its diagnostic and research products. Revenue for the quarter totaled $1.18 billion, up 12% year-over-year. The company attributed the results to strong sales in its Life Sciences and Hematology business segments, with backlog growth and favorable pricing contributing to the momentum. The beat reflects continued resilience in healthcare spending despite macroeconomic headwinds.